伯恩斯坦上调诺和诺德公司评级至”跑赢大市”，看好1300亿美元肥胖药物市场

10 9 月, 2025

One Min Read

14 Views

Last Update: 10 9 月, 2025

Written By

Other Articles

Previous

中信里昂：現時A股走勢仍然健康看好生物科技內險遊戲行業

Next

Twilio CEO interviews candidates for 45 minutes over dinner—he’s listening for one word in particular, and you’re not hired if you say it too much

Related Posts

先消灭低价股！

1 Min Read

假期市场思考：A股还是美股？

1 Min Read

香港证券两日成交额破百亿！港股仍有市场？

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept